Ekso Bionics Raises $5.3M via Convertible Preferred Stock Offering

summarizeSummary

Ekso Bionics finalized a $5.3 million private placement, issuing convertible preferred stock and warrants to institutional investors. The proceeds will be used for working capital and general corporate purposes.

check_boxKey Events

• Private Placement Completed

  Ekso Bionics closed a private placement, issuing Series B Convertible Preferred Stock and warrants, raising approximately $5.3 million after fees.

• Proceeds Allocated

  The company intends to use the net proceeds for working capital and general corporate purposes.

• Registration Rights Agreement

  Ekso Bionics has agreed to file a registration statement for the resale of conversion shares and warrant shares by June 1, 2026.

auto_awesomeAnalysis

Ekso Bionics secured $5.3 million through a private placement, issuing Series B Convertible Preferred Stock and warrants. This capital infusion will support working capital and general corporate needs. The offering includes warrants and preferred stock redeemable after one year, suggesting a need for capital but also offering potential returns to investors.